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ABSTRACT
The disorder of schizophrenia is defined by the presence of positive and negative clinical
symptoms. One of the hallmark positive symptoms is the presence of auditory hallucinations
which have previously been studied to involve bilateral temporal lobe anamolies. Our study
seeks to further define and potentially quantify these anamolies in temporal lobe response by
looking at the correlation of clinical symptoms with temporal lobe activation. To accomplish this
task we have subjected 22 first episode and 64 chronic patients along with 104 matched healthy
controls to a functional MRI scan while undergoing an auditory ‘oddball’ task. Analysis of this
data is unique in the use of independent component analysis (ICA) via Matlab toolbox (GIFT).
Results showed expected positive activation patterns for temporal lobe activity across all
participants but revealed no statistically significant differences within patient populations (first
episode (FE) vs. chronic) or between patients and matched healthy controls. We observed
strong correlation coefficients for both patient groups as positive symptoms were negatively
correlated to temporal lobe response (FE rho = -0.31, chronic rho = -0.20). Negative symptoms
were positively correlated but only statistically significant for first episode patients (rho = +0.23).
This data is consistent with other studies involving EEG recordings of P300 amplitude response.
Finally, in analyzing frontoparietal (FP) lobe activation we showed statistically signficant
activation differences between patients and controls. This result could potentially be used as a
future diagnostic test. In addition, we uncovered another point of asymmetry in first episode
patients whose right FP lobe showed a nearly two-fold correlation coefficient value versus the
left FP lobe for negative symptoms. This unique asymmetry could offer a new area of focus for
future researchers into the pathophysiology of schizophrenia.
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INTRODUCTION
Schizophrenia is a psychotic disorder characterized by abnormal behaviors, incongruent
thought processes and disrupted thought content (Liddle, 1987) which cross-culturally affects
1% of the population worldwide. Currently schizophrenia is a clinical diagnosis based upon the
presence of positive and negative symptoms. As stated in the DSM-IV, positive symptoms
include delusions, hallucinations (most commonly auditory), disorganized speech, and grossly
disorganized or catatonic behavior. Negative symptoms include the presence of a flat affect,
alogia, and avolition.

The pathophysiology of this disease which create these psychological

abnormalities remains an active area of research.
Since auditory hallucinations are a hallmark of the disorder, extensive research has been
conducted on the auditory neural pathyways and its potential dysfunctional nature in patients.
Although studies have uncovered structural analomies in temporal lobe shape and volume
(Engelian) in schizophrenic patients, functional testing has provided more definitive
differentiation amoung schizophrenia patients and healthy controls.

Calhoun showed

successful discrimination between healthy controls and schizophrenia patients based on
auditory cortex testing and bilateral temporal lobe response (Calhoun, Kiehl 2004) . Studies by
Engelien have show that schizophrenia is characterized by disturbed auditory processing which
is suggestive of left temporal lobe abnormalities (Engelien).

In addition, EEG testing in which

an intermittent stimuli elicits an electrical event-related potential (ERP) 300 msec after onset,
commonly known as P300 or P3, has shown a consistent amplitude reduction for schizophrenia
patients (Ford et al. 1992, McCarley et al 1991). The P300 response is generated by multiple
brain regions (including subsets of frontal and parietal cortex) but is also a function of temporal
lobe response (Halgren et al).

We will seek to further define and potentially quantify these

anamolies in temporal lobe response by perfoming functional magnetic resonance imaging
(fMRI) on patients and healthy controls while undergoing an auditory ‘oddball’ task.
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By utilizing fMRI scans we can identify the neural networks across the whole brain as it
engages in auditory processing. We used the auditory ‘oddball’ task both as a way to have
more control over participant’s behavior beyond just “resting” and also to stimulate the brain with
a task that both patients and controls can perform accurately and which is known to elicit robust
brain function differences between the two groups (Kiehl and Liddle, 2001, Kiehl et al 2005b,
Salisbury, et. al 1998). Furthermore, our intent is to use independent component analysis (ICA)
as a means of separating the complex mixed signals arising from the auditory ‘oddball’ task into
individual components with both a spatial brainmap and its timecourse. The application of ICA
analysis to fMRI data provides a means of measurement of both connectivity and taskrelatedness. This allows for the identification of brain networks involving multiple brain regions
as well as the ability to test for which of these networks are affected by schizophrenia (Calhoun,
et al 2001a).

By doing so, we can analyze the differences between patients and controls as

well as between first episode and chronic schizophrenics.

Finally, we seek to analyze the

correlation of clinical symptoms (both positive and negative) on the temporal lobe response.
Although there are studies looking at the relationship of clinical symptoms versus P300
amplitude response the correlation between symptoms and fMRI activation is a new area of
research. Based on work by Debruille, et. al. which found a strong negative correlation between
positive symptoms and P300 amplitude we should expect to uncover similar results. In addition,
we hypothesize that a stronger correlation exists between clinical symptoms and chronic
schizophrenia patients versus first episodes.
Below, we describe our study protocol and provide details on the data processing techniques
used as well as the results and conclusions of our findings.
METHODS
Participants
A subset of study data from a total of 86 patients with schizophrenia and 104 matched
healthy controls were taken from the larger the Mental Illness and Neuroscience Discovery
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(MIND) Clinical Imaging Consortium (MCIC) research project. The MCIC’s group members
include the University of New Mexico in Albuquerque, University of Iowa in Iowa City,
Massachusetts General Hospital in Boston, and the University of Minnesota in Minneapolis. All
subjects were required to be at least age 18 and no older than 60, and to be fluent in English.
The MCIC research protocol provided written informed consent for all study participants and
outlined the criteria for classifying volunteers as either first episode (FE) or chronic
schizophrenia patients or as matched healthy controls. Diagnoses were based on the American
Psychiatric Association DSM IV during an initial interview. First episode patients included those
diagnosed with either schizophrenia, schizophreniform disorder, or schizoaffective disorder.
Chronic patients all carried a diagnosis of schizophrenia. A table outlining the entire critieria for
both first episode and chronic schizophrenia patients is included in the Appendix.

For FE

subjects, an emphasis was placed on finding newly diagnosed schizophrenia patients who were
neuroleptic naïve and fMRI measurements could be obtained prior to long term administration of
any medication.

Scoring of clinical symptoms (positive and negative) for schizophrenia

patientswere based on the Scale for the Assessment of Positive Symptoms (SAPS) and the
Scale for the Assessment of Negative Symptoms (SANS) (Andreasen 1984).

Below is a

breakdown of demographic data of participants:

First Episode
Controls
Average Age
/ Std. Dev.
Gender
Handedness
Parental SES
SAPS
Average /
Std. Dev.
SANS
Average /
Std. Dev.

Table of Demographics
First Episode
Chronic Schiz
Patients
Controls

Chronic Schiz
Patients

25.8 yrs / 6.7 SD

26.4 yrs / 7.7 SD

35.0 yrs / 12.0 SD

36.3 yrs / 11.1 SD

29 M / 23 F
Right: 48
Left: 2
Ambi: 1
No Response: 1
2.62

25 M / 7 F
Right: 27
Left: 2
Ambi: 2
No Response: 1
2.56

58 M / 35 F
Right: 85
Left: 5
Ambi: 3
No Response: 0
2.63

68 M / 22F
Right: 78
Left: 2
Ambi: 6
No Response: 4
2.71

N/A

5.5 / 2.2 SD

N/A

4.3 / 2.9 SD

N/A

8.5 / 3.9 SD

N/A

7.3 / 3.6 SD
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Auditory ‘Oddball’ Task
For the auditory ‘oddball’ task participants wore sound-insulated earphones (Avotec, Stuart,
FL) that presented the auditory stimuli while also shielding them from gradient amplifier noise.
Subjects were expected to respond and press a button with their right index finger every time
they heard a target stimulus and not to respond to a series of standard and novel sounds. The
same auditory stimuli were used and found to be effective in differentiating healthy controls from
schizophrenia subjects (Kiehl and Liddle, 2001; Kiehl et al., 2005). Standard stimuli occurred
with a probability of p = 0.82 and were represented with 1 kHz tones. Target and novel stimuli
were infrequent and each occurred with a probability of p = 0.09 (Fig. 1). Target stimuli were
represented with 1.2 kHz tones and novel stimuli were computer generated complex sounds.
Each stimulus was presented with a pseudorandom order and last for 200 ms. The interstimulus
interval changed randomly in the interval 550-2050 ms and the mean was 1200 ms. A total of
four runs were acquired per session and each run was comprised of 90 stimuli. The sequences
for target and novel stimuli were exchanged between runs to balance their presentation and to
ensure that the activity evoked by the stimuli were not because of the type of the stimulus used.

Figure 1.
Auditory oddball paradigm. Auditory oddball event-related fMRI task.
fMRI Imaging Parameters
FMRI data acquired through either 1.5T or 3T MRI scanners. The University of New Mexico
used at 1.5T scanner, Massachusetts General Hospital, the University of Iowa and the
University of Minnesota used 3.0T scanners. Parameters for these functional scans are as
indicated below:
Pulse sequence = PACE-enabled (on Siemens scanners), Single shot, single echo EPI
Scan plane = oblique axial, AC-PC, copy T2 in-plane prescription
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FOV = 22 cm
27 slices, slice thickness = 4mm, 1 mm skip
TR = 2000 ms
TE = 30ms (3T); 40ms (1.5T - 39ms is ok )

FA = 90 degrees
BW = ±100 kHz =3126 Hz/Px
64.64 matrix, 1 shot

Data Analysis
Data was preprocessed using the software package SPM5 (http://www.fil.ion.ucl.ac.uk/spm/).
Images were motion-corrected using INRIalign – a motion correction algorithm unbiased by
local signal changes (Freire and Mangin 2001; Freire, et al. 2002).

Data were spatially

normalized into the standard Montreal Neurological Institute space (Friston, 1995) and slightly
sub-sampled to 3x3x3 mm, resulting in 53x63x46 voxels. Next the data was spatially smoothed
with a 10x10x10 mm full width at half-maximum Gaussian kernel. The resulting coordinates
were converted to the Talairach and Tournoux standard space for anatomical mapping
(Talairach and Tournoux 1988).
Independent Component Analysis
After the preprocessing was completed, a group ICA was performed on the data (Calhoun,
et. al 2001). A Matlab toolbox known as GIFT, (http://icatb.sourceforge.net version 1.3c), was
used to accomplish this task. ICA is a data-driven multivariate analysis method that identifies
distinct groups of brain regions with the same temporal pattern of hemodynamic signal change.
FMRI time series data for all participants were first compressed through principal component
analysis (PCA). There were 3 data reduction stages in our PCA, in which data were temporally
concatenated for further dimension reduction at each stage. This is a method that has been
shown to be a practical approach to group ICA and was done in order to make the estimation
computationally tractable (Calhoun, et al. 2001, Schmithorst and Holland 2004).

The final

dimensionality of the data was estimated to be 20 maximally independent components using the
modified minimal description length (MDL) criteria tool built into GIFT (Li, et al. 2007). The data
reduction was followed by a group spatial ICA, performed on the participants’ aggregate data,
resulting in the final estimation of our independent components. The algorithm used in this
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process was the Infomax algorithm, which attempts to minimize the mutual information of
network outputs (Bell and Sejnowski, 1995).
Statistical Analysis of ICA Results
From the group spatial ICA, we reconstructed spatial maps and their corresponding ICA time
courses that represented both the spatial and temporal characteristics of each component,
subject, and session. These characteristics are able to depict component and subject group
variability existent in the data. In all, this resulted in 7,600 independent component spatial maps
(190 subjects x 2 sessions x 20 independent components), each with an associated ICA time
course. These maps and time courses were then subjected to a second level analysis to
determine whether the resultant components were task-related or simply noise or artifacts.
We then performed statistical analysis of the spatial components. We averaged the spatial
maps produced during the ICA across the 2 sessions. The spatial maps were then converted to
z-score maps and then entered into a second level one-sample t-test to identify voxels which
contributed significantly to a given component for the group. Next these components were
analyzed statistically and compared with group-specific thresholds to observe regional neural
activations and any potential trends amoung participant groups.
We also statistically analyzed the ICA time courses of each component. We performed a
temporal sorting of the ICA time courses using an SPM5 design matrix containing one regressor
corresponding to the auditory sensorimotor stimuli. Temporal sorting is a method by which we
compare the model’s time course with the ICA generated time course. Using a multiple linear
regression sorting criteria, the concatenated ICA time courses were fit to the model time course.
Upon completion of this step, components were then sorted according to the r-square statistic.
This resulted in a set of beta-weights for each regressor associated with a particular subject and
independent component.

The purpose of this temporal regression was to illustrate the

significance of a particular component with respect to certain characteristics of the experiment
that it represented. In other words, the value of the beta weight indicated the degree to which
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the component was modulated by the auditory task. Next, we calculated the event-related
averages of the time courses for all the components. Each plot of the event-related average
depicts the level of neural activation for that particular component over the course of the
experimental period.
For each independent component in the study, we performed one and two-sample t-tests as
well as averaged the beta weights across particular subject and site subgroups. The voxel-wise
one and two-sample t-tests were performed on the beta values obtained for each component to
detect statistically significant brain or neural network activation amoung first episode, chronic or
healthy controls. Two-sample t-tests were used to compare the differences in activation or
response between experimental groups as follows:
i. chronic patients vs. matched healthy controls,
ii. first episode patients vs. matched healthy controls,
iii. chronics vs. first episode
iv. all schizophrenia patients vs. all matched healthy controls.

Correlation of Task-related Activation with Clinical Symptoms
The final step in our analysis involved identifying any potential correlations between
positive and negative clinical symptoms and ICA component activation. This was done
by conducting Pearson correlations for each independent component across participant
groups (first episode and chronic patients) versus clinical symptoms (positive and
negative).

These comparisons were then statistically thresholded and corrected for

multiple comparisons based on the false discovery rate.
RESULTS
Results of the analysis as outlined previously we identified a large number of independent
components (ICs) which exhibited statistically significant differences between patients and their
matched healthy controls. These ICs included the primary motor cortex (20), the occipital or
visual cortex (12 & 19) and the default mode (4 & 5). For the purposes of this study we will
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focus on the results for the temporal lobes (IC# 13 and 17) and the frontoparietal lobes (IC# 7
and 9).
Temporal Lobe Results
For the temporal lobe, one-sample t-tests revealed positive direction activation for all
participant groups (see figure 1 below).

Beta-Weights

Temporal Lobe Activation
14
12
10
8
6
4
2
0
First Episode
Patients

First Episode
Controls
Standard

Chronic Patients Chronic Controls

Novel

Target

Figure 1. Temporal Lobe Activation under Auditory ‘Oddball’ Task

However, based on the results of two-sample t-tests there was no statistically significant
difference in activation between patients (first episode or chronic) and their matched healthy
controls.

In addition, no difference in temporal lobe response existed within the patient

populations (first episode versus chronic).
Correlation coefficients between temporal lobe response and clinical symptoms were
calculated and then thresholded at a p-value of <0.05 (FDR corrected) using a nonparametric
permutation approach. For the temporal lobe areas, chronic and first episode patients, showed
statistically significant correlation with positive and negative symptoms:

First Episode
Patients

Chronic
Patients

Positive
Symptoms

rho = -0.31

rho = -.20

Negative
Symptoms

rho = 0.23

n/a
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Frontoparietal (FP) Lobes
For the left frontoparietal lobe, one-sample t-tests revealed positive activation for all
participant groups (see figure 2 below).

For the right frontoparietal lobe, activation was mixed

and was shown to be significant only for target tones during the auditory task by first episode
patients (target, t=2.23 df=21) and matched healthy chronic controls (target t=3.33 df=73).
Left Frontoparietal Lobe Activation
14

beta-weights

12
10
8
6
4
2
0
First Episode First Episode
Patients
Controls

Standard

Chronic
Patients

Novel

Chronic
Controls

Target

Figure 2. Frontoparietal Lobe Activation under Auditory ‘Oddball’ Task.

Two-sample t-tests revealed statistically significant differences in FP lobe activation between
patients and controls. The table below outlines the statistically significant response differences
between patient and control groups for both left and right lobes.
Two-Sample T-test
Left Fronto-Parietal FE Patients vs
Lobe
FE Controls

Chronic Patients vs
Chronic Controls

All Patients vs
All Controls

Novel

2.41

3.29

4.07

Target

2.83

4.60

5.42

FE Patients vs
FE Controls

FE vs. Chronic
Patients

Right FrontoParietal Lobe
Standard

2.38

2.39

The calculated correlation coefficients between chronic patients and right FP lobe activation
only showed significance for positive symptoms (+0.19). For first episode patients, the table
below highlights the correlation values across both lobes.
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First Episode
Patients
Frontoparietal Lobe
Positive
Symptoms
Negative
Symptoms

Left

Right

-0.21

-

0.22

0.43

DISCUSSION
Looking at the results for temporal lobe activation, our analysis is consistent with other
similar studies involving fMRI data and P300 amplitude response.

The lack of statistically

significant differences in temporal lobe response between patients and healthy controls was
previously highlighted in a study by Kiehl, et. al (2001). Debruille found the same negative
relationship existed between the degree of temporal lobe activation and positive clinical
symptoms. However our data did uncover a larger negative correlation amoung first episode
versus chronic patients with respect to positive symptoms. The explanation for this difference
would require more analysis as it may simply be a function of age difference between patient
populations or it could be the effects of long term drug treatment. A study by Jones looking at
quetiapine in first episode patients showed that “During auditory stimulation, the healthy control
group and stably treated group produced significantly greater activation in the superior temporal
gyrus than the drug naïve sample.” Looking at our one sample t-test data, we would tend to
support this statement. However, further work would need to be done to highlight the average
dose years of our chronic schizophrenia patients to confirm this secondary finding.
Although our original focus was on the temporal lobe we offer up the results of the bilateral
frontoparietal regions as this area was consistently activated in other studies (in particular P300
measurements) during auditory cortex stimulation. Our results show that patient stimulation of
left frontoparietal regions was consistently and statistically larger in response as compared to
matched heathly controls when exposed to both novel and target stimuli during the auditory
oddball task.

This differentiation between patients and controls could represent a future
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diagnostic test to diagnose patients.

Of course, more extensive research and study would be

required to confirm this data and to begin to quantify the sensitivity and specificity of such a
diagnostic test. What’s intriguing about this possibility is that fact that the results also showed a
statistically significant difference in the right FP lobe within the patient population (FE vs. chronic
for Standard tones) which could potentially be exploited to track disease progression.
Finally, we see the same pattern in correlation coefficients for first episode patients for FP
lobes as for temporal lobes; namely positive symptoms were negatively correlated as negative
symptoms were positively correlated. These correlation relationships seem reasonable since
increased severity of positive symptoms suggest increased psychosis which would tend to
further impair attention to task performance and decrease brain activation.
Another interesting finding of our results is the asymmetry in correlation values for negative
symptoms for FE patients. The data shows a nearly two-fold larger correlation coefficient for
right versus left FP lobe activation. Previous studies have highlighted a consistently larger
negative correlation in left temporal lobe response as measured in P300 amplitude (McCarley).
This new asymmetry may suggest a new area of focus for future researchers and given that it is
statistically significant only for FE patients could suggest a point of origin for the
pathophysiology of schizophrenia. Clearly, this results needs more investigation.
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APPENDIX
From the MCIC Protocol:
All Subjects must meet be the following inclusion / exclusion critieria:
All subjects will be fluent in English. If a subject agrees to participate, informed consent will be
obtained following consideration of the following exclusion criteria based on current
recommendations for fMRI studies:
• History of neurologic or psychiatric disease other than schizophrenia
• History of head injury resulting in prolonged loss of consciousness and/or
neurological sequelae
• History of skull fracture
• History of epilepsy, except for childhood febrile seizures
• History of prior neurosurgical procedure
• Substance abuse or dependence within the past month
• Use of inhalants
• Metal in the head, metal injury to the eyes
• Implanted pacemaker, medication pump, vagal stimulator, deep brain stimulator,
TENS unit, or ventriculo-peritoneal shunt
• Pregnancy (If the patient cannot rule out the possibility of pregnancy, a pregnancy
test will be conducted prior to study)
• IQ less than or equal to 70, based on a standard IQ test or the ANART
All First Episode (FE) subjects will be between 18-60 years of age.
Additionally, all FE subjects will be defined and categorized into the following:
1. Psychotic symptoms of any duration with a lifetime exposure of 10mg or less of haloperidol
equivalents.
2. Psychotic symptoms <5 years with a lifetime exposure of 10mg or less of haloperidol
equivalents.
3. Psychotic symptoms of <5 years with a lifetime exposure of 12 weeks of antipsychotic
exposure but none in the last 3 weeks.
4. Psychotic symptoms of <5 years with a lifetime exposure of 12 weeks of antipsychotic
exposure with some in the last 3 weeks.
5. Psychotic symptoms of <2 years duration, combined with no more than 6 months of
antipsychotic exposure.
Chronic Patients Definition:
The chronic patients will meet the inclusion/exclusion criteria and be 18-60 years of age and will
be limited to patients with a DSM diagnosis of schizophrenia who do not fit the FE categories
above.
Healthy Matched Contols:
The healthy volunteer subjects will also be recruited from the community through newspaper
advertising. They will be carefully screened using a structured interview to rule out medical,
neurological, and psychiatric illnesses, including substance abuse. They will be assessed at
intake and followed longitudinally.
Healthy normal volunteers who have not been diagnosed with any psychiatric disorders, but
who have been medicated with antidepressants, antianxiety medication and medication for
sleep deprivation, can be included in the study, provided that the duration of the medication
does not exceed 2 months of continuous use at any time and they have not been used at least 6
months prior to the scan.
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